首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Revue du rhumatisme (edition francaise)

缩写:

ISSN:1169-8330

e-ISSN:1768-3130

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引378
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
A Saraux,D Bouillin,P Jeandel et al. A Saraux et al.
Although endemic fluorosis occurs in many countries, epidemiological studies have been limited by funding problems, a lack of awareness of the public health impact of the disease, and the absence of inexpensive defluoridation methods. The e...
M Alcalay,I Chartier,O Garrouste et al. M Alcalay et al.
Disk herniation can manifest as isolated low back pain, which is usually intermittent and accompanied with stiffness of the lumbar spine. There is almost general agreement that neither neurosurgical treatment nor chemonucleolysis is appropr...
F Simon,P Y Chouc,V Hervé et al. F Simon et al.
The authors report a case of disseminated African histoplasmosis with bone and joint involvement in a black 28-year-old citizen of the Central African Republic who presented with a 17-month history of multiple osteoarticular lesions (sterno...
P Gallien,B Nicolas,M P Le Bot et al. P Gallien et al.
Heterotopic ossification is common in patients with spinal cord or brain injury. Whereas the articular complications of heterotopic ossification have been well documented, the vascular complications are less well known. We report three case...
P Calmels,A Pereira,M Domenach et al. P Calmels et al.
Functional disability and quality of life were evaluated using the Functional Independence Measure and the Reintegration to Normal Living Index, respectively, in 57 subjects (15 men and 42 women) with a mean disease duration of 15 years. Sc...
R M Flipo,P Bertin,B Combe et al. R M Flipo et al.
Although the efficacy of cyclosporine therapy in rheumatoid arthritis has been established, there have been no long term studies of the risk/benefit ratio of cyclosporine A in severe rheumatoid arthritis. A prospective, open-label one-year ...